Methods of Information in Medicine

LinksSchließen

Referenz

Jänne PA, Smith I, McWalter G, Mann H, Dougherty B, Walker J. et al.
Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced nonsmall-cell lung cancer.

Br J Cancer 2015;
113 (02) 199-203.

Bibliographische Angaben herunterladen

Aufrufen in: